Production (Stage)
Ikena Oncology, Inc.
IKNA
$1.43
$0.064.38%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 45.00K | 3.72M | 4.58M | 6.82M | 400.00K |
| Gross Profit | -45.00K | -3.72M | -4.58M | -6.82M | -400.00K |
| SG&A Expenses | 4.42M | 5.64M | 7.60M | 4.78M | 5.31M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.44M | 9.36M | 12.18M | 11.60M | 15.14M |
| Operating Income | -8.44M | -9.36M | -12.18M | -11.60M | -15.14M |
| Income Before Tax | -2.75M | -8.59M | -9.07M | -10.22M | -13.67M |
| Income Tax Expenses | 15.00K | 28.00K | 53.00K | 10.00K | 62.00K |
| Earnings from Continuing Operations | -2.77M | -8.62M | -9.12M | -10.23M | -13.73M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.77M | -8.62M | -9.12M | -10.23M | -13.73M |
| EBIT | -8.44M | -9.36M | -12.18M | -11.60M | -15.14M |
| EBITDA | -8.35M | -9.27M | -12.09M | -11.51M | -15.05M |
| EPS Basic | -0.06 | -0.18 | -0.19 | -0.21 | -0.28 |
| Normalized Basic EPS | -0.03 | -0.09 | -0.11 | -0.12 | -0.17 |
| EPS Diluted | -0.06 | -0.18 | -0.19 | -0.21 | -0.28 |
| Normalized Diluted EPS | -0.03 | -0.09 | -0.11 | -0.12 | -0.17 |
| Average Basic Shares Outstanding | 48.26M | 48.26M | 48.26M | 48.26M | 48.26M |
| Average Diluted Shares Outstanding | 48.26M | 48.26M | 48.26M | 48.26M | 48.26M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |